rhil-15
Showing 1 - 2 of 2
Leukemia, Lymphocytic, Chronic Trial run by the NCI (rhIL-15, Obinutuzumab)
Terminated
- Leukemia
- +3 more
- rhIL-15
- Obinutuzumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 11, 2022
Clear-Cell Renal Carcinoma Trial run by the NCI (rhIL-15, Avelumab)
Terminated
- Clear-Cell Renal Carcinoma
- rhIL-15
- Avelumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 27, 2022